Inhalant Abuse During Pregnancy: Risks of Birth Defects and Developmental Harm

Inhalants are volatile substances inhaled for psychoactive effects. Common categories:

• Volatile solvents (paint thinner, glue, nail polish remover)
• Aerosols (spray paint, hairspray)
• Gases (butane, propane, nitrous oxide)
• Nitrites (amyl, butyl – "poppers")

Acute Maternal Effects

Intoxication, dizziness, slurred speech, ataxia, hallucinations, nausea, seizures, coma, sudden sniffing death (cardiac arrhythmia).

Teratogenic Effects on Fetus

• Structural malformations: Cardiac defects, renal anomalies, limb reductions, cleft lip/palate, neural tube defects.
• Growth restriction: Low birth weight, microcephaly.
• Neurodevelopmental: Cognitive deficits, behavioral problems, attention deficits, motor delays.
• Fetal solvent syndrome: Phenotype resembling fetal alcohol syndrome (facial dysmorphism, growth deficiency, CNS abnormalities).

Mechanisms

Lipophilic solvents cross placenta readily. Disrupt cell migration, differentiation, apoptosis; cause oxidative stress, hypoxia.

Prevention & Intervention

• Screen for substance use in prenatal care (validated tools).
• Brief intervention, motivational interviewing.
• Referral to specialized addiction treatment (limited for inhalants).
• Environmental removal of inhalants.
• Education on risks.

No safe level of inhalant use in pregnancy. Early cessation improves outcomes.